at any time of the year to protect the musculoskeletal health. 
4-8
In the light of this, we sought to investigate whether there were differences between serum total and directly measured free 25OHD
concentrations between Asians and White Caucasians and the changes in these parameters following administration of a single dose of 150 000 IU of vitamin D3. In addition, we aimed to determine the effect of covariates including DBP concentration and genotype, concurrent diet and skin colour on both the free and total 25OHD responses, and the extent of parathyroid hormone (PTH) suppression following dosing.
| MATERIAL S AND ME THODS

| Study design
This was an exploratory study to determine the size of the effect on serum free and total 25OHD of a 150 000 unit dose of vitamin D 3 , given to young adults from different ethnic groups ( Figure 1 ).
| Study participants
We recruited a cohort of sixty apparently healthy young adult men from two ethnic groups-White Caucasian (n = 30) or South-East Asian (n = 30) origin. 
| Skin type, season and sun exposure
Skin type was assessed using a 6-point Fitzpatrick scale in all subjects at baseline. 9 Fitzpatrick one skin type is fair and freckled; type six is very dark/black. The study was conducted in the UK during January and February to avoid sun exposure.
| Samples
| Baseline
Fasting blood samples were collected for serum total 25OHD, free 25OHD, calcium, phosphate, magnesium, albumin, alkaline phosphatase, PTH, DBP and DBP genotype.
| Four weeks
All blood investigations (except DBP genotype) were repeated.
| Urinary calcium: creatinine ratio
A fasting second void urine sample for calcium:creatinine ratio was collected at baseline, 1 and 4 weeks after vitamin D3 administration. 
| Vitamin D3 dosing
| Laboratory methods
| Serum total 25OHD
Serum total 25OHD levels were determined using an UPLC/Mass Spectrometer Semi-automated hexane extraction in the Acquity Ultra Performance LC/Quattro MS (Waters) analyser. Lower limit of detection for 25OHD 2 was 6 nmol/L and for 25OHD 3 3.5 nmol/L.
The interassay coefficient of variation (CV) for 25OHD 2 and 25OHD 3 was 5.7% and 5.4%, respectively.
| Serum free 25OHD
Free 25OHD levels were measured using an ELISA from Future Diagnostics Solutions. The interassay CV was 4.8%. 
| Serum vitamin D binding protein
| Intact Parathyroid hormone (PTH)
Parathyroid hormone was measured using Immunoassay 
| DBP genotyping
A pyrosequencing assay was developed in house, using PSQ assay design software version 1.0.6 (Qiagen), to detect two single-nucleotide polymorphisms (SNPs), rs4588 and rs7041 in the DBP gene, that give rise to three common variants of DBP (a) Gc1f (b) Gc1s and (c) Gc2. All subjects were genotyped for six different haplotypes-Gc1f-1f, Gc1f-1s, Gc1f-2, Gc1s-1s, Gc1s-2 and Gc2-2, ranked here in order of 25OHD binding affinity, highest to lowest.
PCR and sequencing primers were as follows: 
| Calculated free and bioavailable 25OHD
Free and bioavailable 25OHD levels based on fixed affinity constant for the DBP genotype (Gc1f-1f) were calculated using the mathematical model described by Chun et al 11
| Sample size
This was an exploratory study to determine effect size and variance; hence, no formal calculation of sample size was undertaken. We sought advice from the Yorkshire and Humber
Research Design Service who suggested that a sample size of 30
per group was sufficient to undertake exploratory work of this nature.
| Statistical methods
Continuously distributed data were summarized by the median (25th/75th centiles), categorical data by n(%). Missing values are tabulated but not considered otherwise in our analysis.
Normality checks were carried out; data were generally normally or near-normally distributed, and hence, parametric tests were used to assess differences between groups.
To compare the groups prior to dosing, two sample t tests of baseline characteristics were performed and are reported in Table 1 .
The main question of interest was whether ethnicity impacted on change in total and free 25OHD following dosing. Two sample t tests were carried out to compare the changes in total and free 25OHD between the groups. Analysis of variance was also used to determine any other statistical differences between the groups and adjust for covariates. Generalized linear models were used to determine statistical differences between response variables that had error distribution models other than normal, and to assess the interactive effect of ethnicity and DBP on change in free 25OHD.
Fisher's exact test was used to compare the categorical data.
Graphical presentation was made by Box and Whisker plot. P values were used sparingly with an arbitrary threshold of 0.05 (two-tailed).
We performed all our analyses using Statistical Package for 
| RE SULTS
| Baseline clinical characteristics
The baseline clinical characteristics of the study subjects are shown in 
| Influence of ethnicity on measured parameters at baseline and following intervention
Twenty-nine participants of the 60 recruited had a serum total 25OHD level of <30 mnmol/L at baseline, of which 60% (18/30) were Asian and 36% (11/30) were White Caucasian (Table 1) . Asians had significantly lower serum total 25OHD and DBP levels, but similar measured and calculated free 25OHD levels compared to White Caucasians at baseline (Table 3) . At 4 weeks, the changes in serum total 25OHD, DBP and calculated free 25OHD levels were similar between Asians and White Caucasians; however, the increase in directly measured serum free 25OHD level was significantly greater in Asians 18.1(9.4) vs 12.2 (13.3) pmol/L in Caucasians (P = 0.0464) ( Table 3 ) (Figure 2A , B and C).
Although the observed significance was marginal, we considered it to be acceptable for a preliminary study.
There was a significant interaction (P = <0.01) between ethnicity and mean DBP in relation to change in free 25OHD following dosing. In
Caucasians, a lower mean DBP was associated with a larger in an increase in measured free 25OHD; this was not true for Asians, in whom the relationship of free 25OHD with mean DBP was positive, that is as mean DBP increased, the change in free 25OHD also increased ( Figure 2D ).
We found no clear effect of DBP haplotype within the ethnic group on change in either total or free 25OHD, either alone or in combination with other factors.
Baseline PTH concentration was higher in Asians than in White Caucasians (P = 0.0019) ( Table 3) . Following intervention, no significant changes in PTH levels were noted in either of the groups (Table 3) . No increase in urine calcium: creatinine ratio was noted at either 1 or 4 weeks postintervention. 
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TA B L E 3
Results showing serum total and free 25OHD levels, estimated 25OHD and parathyroid hormone (PTH) levels at baseline and increment postsupplementation, mean and SD 95% CI -3.54, 3.05 pmol/L). There is a significant proportional bias (slope = 0.43, 95% CI 0.24, 0.71 pmol/L) ( Figure 3C ).
Bland-Altman plot postsupplementation shows no evidence of bias ( Figure 3B ).
Passing-Bablok plot postsupplementation shows a large negative systematic bias (−13.29 pmol/L). This is not statistically significant (95% CI -33.82, 2.99 pmol/L). There is no significant proportional bias (slope = 1.04, 95% CI 0.54, 1.70 pmol/L) ( Figure 3D ).
| Relationship of PTH with total and free 25OHD
There was a statistically significant negative correlation between PTH and total 25OHD at baseline (r = −0.442; P = 0.0006) and postintervention (r = −0.452; P = 0.0004). However, the relationship of PTH at baseline with measured free 25OHD did not reach significance at baseline (r = −0.245; P = 0.0634) or following intervention (r = −0.061; P = 0.6446).
| Relationship of skin type with total and free 25OHD
There was no statistically significant difference between skin types and baseline total 25OHD concentrations by one-way ANOVA (F (4,54) = 2.08, P = 0.0956). Postdosing total 25OHD also did not differ between skin types.
| Relationship of DBP genotypes on total and free 25OHD
There were no significant differences by DBP genotype for baseline total 25OHD (F ratio = 1.0075, P = 0.4225) or serum free 25OHD (F ratio = 0.4838, P = 0.7868). Following intervention, subjects with Gc1f-1s haplotype (high affinity for 25OHD) showed the greatest increment in serum total 25OHD (increment 60.65 (17.3) nmol/L; baseline 32.9 (14.0) nmol/L). Subjects with the lowest affinity haplotype Gc2-2 had the smallest increment in serum total 25OHD (increment 48.9 (6.9) nmol/L, baseline 18.4 (3.6) nmol/L).
The increment in serum direct free 25OHD levels was greatest in subjects with the Gc2-1s (16.6 (10.2) pmol/L; low-affinity haplotype), and lowest in subjects with Gc1f-1f (10.1 (11.9) pmol/L highest affinity haplotype). None of these differences reached statistical significance, however.
| Relationship of dietary calcium and vitamin D intake with PTH, DBP, total and free 25OHD
There was no relationship of dietary calcium intake at baseline with baseline PTH, DBP, total or free 25OHD, or change in any of those parameters, either for the whole group or by ethnicity. 
| D ISCUSS I ON
We found that serum total 25OHD was low in young men of White There is a biochemical basis for the differences in affinity of the different DBPs for vitamin D metabolites. Polymorphisms in the Gc gene (codominant alleles) give rise to three major electrophoretic variants of Gc (Gc1f, Gc1s and Gc2), which differ by amino acid substitutions as well as glycosylation. 15 The amino acid sequence of the three isoforms 1f, 1s and 2 differ at positions 152, 311, 416 and 420. Calculated estimates of free 25OHD were found to be significantly different from direct measurements and showed a systematic bias. According to the free hormone hypothesis, 5 the biological action of 25OHD is exerted by its freely available form (<1% of the total), not by the total circulating amount which comprises DBPbound (85%-90%) and albumin-bound (10%-15%) forms plus free.
There is support also for the concept of bioavailable 25OHD, 17 comprising the albumin-bound and free fractions, suggesting that measurement of free or bioavailable 25OHD concentration may provide a more meaningful marker of vitamin D function than total. 
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The authors reported that the difference in DBP levels between the Africans and White people identified using a monoclonal assay disappeared when measured using polyclonal or proteomic methods.
This contrasts with our results; we found a significant difference in DBP levels between the Asians and White Caucasians using the polyclonal assay. Lower DBP levels have previously been documented in carriers of two Gc2 alleles. [22] [23] [24] We found no clear effect of genotype either at baseline or following intervention on serum DBP, irrespective of ethnicity. As our population size is small, the results in relation to DBP and genotype should be considered preliminary and thus need confirming in a larger population.
We found directly measured serum free 25OHD at baseline in Asians and Caucasians to be very similar despite lower total 25OHD in Asians. We hypothesized originally that the lower DBP concentrations found in the Asians in our cohort were likely to be the reason for their comparable levels of free 25OHD. Following intervention with vitamin D3, no change in DBP levels was observed in either Asians or White Caucasians when compared to baseline, indicating that the serum DBP concentration is not altered by single-dose supplementation. Our findings agree with those of with Sollid, where no effect of vitamin D3 on serum DBP concentration was shown in an interventional trial (20 000 IU D3 weekly for a year) in Caucasians. 24 We found a higher increment in measured free 25OHD concentration in Asians following vitamin D3 supplementation, despite a similar increment in total 25OHD concentration and no significant change in DBP concentration. In addition, the incremental increase in Caucasians' serum free 25OHD was inversely related to both baseline and mean DBP, whereas in Asians, it was not. This implies would be therefore that significantly increasing calcium absorption might have unexpected and undesirable consequences in an ethnic group already at higher risk for cardiovascular and renal disease.
In the method comparison between the calculated and directly measured serum free 25OHD using fixed affinity constant for the DBP genotype, there was a positive but not significant systematic bias at baseline. Postsupplementation, the systematic bias was negative and also nonsignificant. We cannot explain this finding. This may be due to small sample size ( Figure 3A ,B,C and D).
| S TRENG TH S AND LIMITATI ON S
Ours is the first interventional study reported so far, studying the effects of single dose of vitamin D3 on serum total 25OHD, DBP and free 25OHD concentration in both Asians and Caucasians. The main limitation of our study is the small sample size; hence, we had an insufficient statistical power to demonstrate the influence of skin types or DBP genotypes on serum 25OHD (total and free) with or without vitamin D 3 supplementation. We conducted the study exclusively in young healthy males; hence, our study findings may not be applicable to conditions associated with variation in DBP levels such as gender, pregnancy, liver disease and infections, and may not necessarily be applicable across all ages. We also included no functional outcome measures.
| CON CLUS ION
Our primary aim was to determine the size of the effect of vitamin D supplementation in different ethnic groups. In an era of "precision medicine," we should be able to better target vitamin D treatment. Rather than adopting a "one size fits all" policy, we should aim to develop measurements that accurately reflect vitamin D status across all ethnic groups, and use these to guide treatment for relevant functional outcomes.
ACK N OWLED G EM ENTS
We thank study volunteers for their participation and acknowl- 
CO N FLI C T O F I NTE R E S T
Dr Jaya Sujatha Gopal-Kothandapani declares no competing interests. 
Miss
R E FE R E N C E S
